PN 76039
RN 00394 
AN 76115480
AU Gibbons-A.  Allan-J-D.  Holzel-A.  McFarlane-H.
TI Cell-mediated immunity in patients with cystic fibrosis.
SO Br-Med-J. 1976 Jan 17. 1(6002). P 120-2.
MJ CYSTIC-FIBROSIS: im.  IMMUNITY-CELLULAR.
MN ADOLESCENCE.  ADULT.  ANTIGENS.  ANTIGENS-FUNGAL.
   ASPERGILLUS-FUMIGATUS: im.  CELL-MIGRATION-INHIBITION.  CHILD.
   CHILD-PRESCHOOL.  CYSTIC-FIBROSIS: dt.  FEMALE.  GUINEA-PIGS.  HUMAN.
   INFANT.  LEUKOCYTES: im.  LUNG: im.  MACROPHAGES: im.  MALE.
   PANCREAS: im.  PREDNISOLONE: tu.  PSEUDOMONAS-AERUGINOSA: im.
AB Leucocytes from 26 patients with cystic fibrosis (CF) and 18 healthy
   controls were investigated by migration inhibition induced by a
   variety of antigens. In patients with CF cell-mediated immunity was
   found to human lung and pancreatic tissue extracts as well as to
   Aspergillus fumigatus, Pseudomonas aeruginosa, and food antigens but
   not to brain, heart, or kidney. Those patients with the severest form
   of the disease had the greatest impairment of cell-mediated immunity,
   but this impairment could be reversed by steroid treatment. Cell-
   mediated cytotoxicity may also be concerned in the pathogenesis of
   CF.
RF 001   MURRAY MJ             ANN INTERN MED                  53   548 960
   002   STEIN AA              J PEDIATR                       65   495 964
   003   MEARNS MB             THORAX                          20   385 965
   004   MEARNS MB             LANCET                           1   538 967
   005   WARREN CPW            CLIN ALLERGY                     5     1 975
   006   MCFARLANE H           BR MED J                         1   423 975
   007   SOBORG M              ACTA MED SCAND                 181   247 967
   008   MORLEY J              IN: WEIR DM                      2    20 973
   009   PEPYS J               PROC INT CONG ALLERGOLOGY        6   221 968
   010   WALLWORK JC           CLIN EXP IMMUNOL                18   303 974
   011   CRACCO G              PROC EWGCF 5TH ANNU MTG               16 974
   012   GELL PGH              CLINICAL ASPECTS OF IMMUNOLOG            968
   013   MCFARLANE H           CF NEWS                         10     6 975
CT   1   FEIGHERY C            BR MED J                         1   524 976
     2   MCFARLANE H           LANCET                           1  1241 976
     3   ANON                  NUTR REV                        34   210 976
     4   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     5   RAEBURN JA            PROC NUTR SOC                   36    77 977
     6   GORMAN NT             J NATL CANCER INST              61  1095 978
     7   GOTZ M                EUR J PEDIATR                  127   133 978
     8   HOIBY N               ACTA PAEDIATR SCAND             68   495 979
     9   HODSON ME             THORAX                          35   801 980
    10   MIELIVERGANI G        ARCH DIS CHILD                  55   696 980
    11   MARESZBABCZYSZYN J    ARCH IMMUNOL THER EXP           31   199 983
    12   MARESZBABCZYSZYN J    ARCH IMMUNOL THER EXP           31   217 983
    13   PORWOLL JM            INFECT IMMUN                    40   670 983
    14   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985
    15   FERGUSON A            HUM NUTR CLIN NUTR             40C   255 986